Efficacy and safety of evolocumab (AMG 145), a fully human monoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trials.
暂无分享,去创建一个
R. Giugliano | M. Sabatine | R. Weiss | F. Raal | E. Stein | D. Sullivan | S. Wasserman | R. Scott | Thomas Liu | M. Koren | Jae B. Kim | E. Roth | Moetaz B Albizem | R. Somaratne | Jingyuan Yang